Inhibitor Therapeutics Balance Sheet
Inhibitor Therapeutics's total assets for Q4 2025 were $2.51M, a decrease of -19.90% from the previous quarter. INTI total liabilities were $3.80M for the fiscal quarter, a 21.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.